Investor Relations


 Share This ArticleSubmit to FacebookSubmit to Google BookmarksSubmit to TwitterSubmit to LinkedIn

TAKE Solutions reports a strong growth of 30.5% in FY17 revenue

image01

TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a globally recognized knowledge and innovation intensive Life Sciences expert, today announced its financial results for Q4 and year ended FY17.

Read more

TAKE Solutions Augments Executive Management Team

image01

TAKE Solutions announced the appointment of Dr. Krishnan Rajagopalan as Chief Growth Officer for its Life Sciences business “Navitas”.

Read more

TAKE Solutions conferred with ‘Special Commendation’ at the Golden Peacock Awards 2016’

image01

TAKE Solutions, a global knowledge intensive Life Science Technology company, announced that it has been conferred with a ‘Special Commendation’ for Excellence in Corporate Governance at Golden Peacock Awards.

Read more

Upcoming Events

Annual general meeting – 11 Aug 2017

Board Meeting – 14 Aug 2017

Board Meetings

18-05-2017 Audited Results & Final Dividend
02-02-2017 Quarterly Results & Interim Dividend
03-11-2016 Quarterly Results & Interim Dividend
04-08-2016 Quarterly Results
12-05-2016 Audited Results & Final Dividend

Contact Details

Contact Us

For LS sales call (Princeton, US) +1 877 320 3626 X 230
For SCM sales call (Austin, US) +1 800 324 5143

General Enquiry: contact@takesolutions.com
Financial and Investor Queries: investorrelations@takesolutions.com
Career related Queries: career@takesolutions.com
Media Queries: media@takesolutions.com
Website Feedback: webmaster@takesolutions.com
  • ShareThis


Sitemap | RSS Feeds              Privacy Policy | Terms
© TAKE Solutions 2017